Clinical
RSSArticles
When Lawmakers Make Medical Decisions, Patients and Providers Suffer
Recent suggests a future in which doctors in abortion-ban states will have to ask how much of a threat of death is needed before they can give patients the care needed to prevent their death or serious morbidity.
Too Many Physicians Lack Accurate Information About Contraception
New research revealed that a significant number of physicians hold erroneous beliefs about how contraceptives work. Many believe emergency contraception causes abortions, and some doctors believe IUDs and other forms of birth control also work as abortifacients, according to a study of Wisconsin physicians’ beliefs about contraception.
Reproductive Health Workforce May Look Different in 10 Years
The reproductive health workforce has changed considerably in the past few years. It is possible it will continue to evolve over the next decade. COVID-19 placed an incredible strain on the workforce, and it is facing a second huge strain because of the U.S. Supreme Court’s decision to overturn Roe v. Wade.
What Will Happen to the Reproductive Healthcare Workforce?
Months after Roe v. Wade was overturned, reproductive healthcare providers and patients are experiencing enormous — and sometimes disastrous — changes. For instance, state abortion bans are expected to affect where OB/GYNs and other reproductive health clinicians choose to study and practice. These bans also will affect how and whether medical students and residents are fully educated in contraceptive care and counseling, abortion care, miscarriage care, ectopic pregnancy treatment, and high-risk pregnancy care.
Current and Future Options for Male Contraception
Following the landmark Dobbs v. Jackson Women’s Health Organization decision that ended the constitutional right to abortion in the United States, the importance of contraception has grown. This article summarizes the existing male contraceptive options and reviews the status of future ones.
Ibrexafungerp for Vulvovaginal Candidiasis
A randomized clinical trial compared one day of oral ibrexafungerp with placebo for female patients with vulvovaginal candidiasis (VVC). It found ibrexafungerp to be safe and effective, with mild diarrhea the most common adverse event. Ibrexafungerp differs mechanistically from azoles and appears to be a promising new treatment for VVC.
Effectiveness of an Online e-Health Program in Ameliorating Postpartum Depression
This study demonstrated that combined use of universal depression screening and MomMoodBooster2, a cognitive behavioral therapy-based e-health program, were effective tools for treating women with depression in the perinatal period.
A Simple Intervention to Reduce Surgical Site Infections?
This multicenter, cluster randomized trial in Benin, Ghana, India, Mexico, Nigeria, Rwanda, and South Africa evaluated the effect of changing sterile gloves and instruments at the time of abdominal wound closure on surgical site infection (SSI) rates among adults and children undergoing both elective and emergent surgery. The SSI rate in the intervention group among 5,789 patients was 16% compared to 18.9% in the control group of 6,768 patients (adjusted risk ratio, 0.87; 95% confidence interval, 0.79-0.95).
Teplizumab-mzwv Injection (Tzield)
Teplizumab can be prescribed to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients age 8 years and older with stage 2 type 1 diabetes.
It’s Not All About the Cough
Be careful about relying on clinical queries that focus on the presence of cough for two or more weeks, which could lead to delays in the diagnosis of nearly half of pulmonary tuberculosis cases.